Conference Features Renowned Translational Cancer Researchers and Updates on Key Discoveries, Plus Panel Discussion with Academic and Industry Leaders
NEW YORK, April 8 /PRNewswire-USNewswire/ -- Internationally renowned physician-scientists will discuss the rapidly changing cancer research landscape in the US, plus important recent discoveries in translational cancer research, during the first Damon Runyon Cancer Research Foundation Clinical Investigator Symposium.
The April 27th event, to be held in partnership with the New York Academy of Sciences, includes a panel discussion on the evolving partnership between academia and industry in research and drug development.
Presenting Damon Runyon Clinical Investigators include:
The symposium marks the 10th anniversary of the prestigious Damon Runyon Clinical Investigator Award, which addresses the critical demand for physicians capable of translating scientific discovery into new breakthroughs for cancer patients.
Media coverage of this event is encouraged.
Contact: Catherine Bright Damon Runyon Cancer Research Foundation 212.455.0506 or email@example.com Bill Silberg New York Academy of Sciences 212.298.8646 or BSilberg@nyas.org
To see the event detail page, including agenda, speaker bios, scientific advisory committee and sign-up info, go to http://www.nyas.org/events/eventDetail.asp?eventID=12060&date=4/27/2009%208:00:00%20AM
The Damon Runyon Cancer Research Foundation's mission is to find the most brilliant and promising scientists and provide them with funding to pursue innovative research that will eliminate cancer as a deadly disease. Our strategy is to:
Eleven scientists supported by the Foundation have received the Nobel Prize. Since 1946, the Foundation has invested over $220 million and funded more than 3,200 scientists.
100% of all donations to the Foundation are used to support scientific research. Administrative and fundraising costs are paid from its Damon Runyon Broadway Tickets Service and endowment.
The Damon Runyon Clinical Investigator Award selects top early-career physician-scientists conducting patient-oriented cancer research and provides them with the resources and training essential to becoming leaders in this important field. Since 2000, the Foundation has committed more than $30 million to support 44 exceptional physician-scientists from across the United States.
For more information visit www.damonrunyon.org
Founded in 1817, the New York Academy of Sciences (NYAS) is an independent, nonprofit organization committed to advancing science, technology, and society worldwide. With about 24,000 members in 140 countries, NYAS is creating a global community of science for the benefit of humanity. NYAS' core mission is to advance scientific knowledge, positively impact the major global challenges of society with science-based solutions, and increase the number of scientifically informed individuals in society at large.
|SOURCE Damon Runyon Cancer Research Foundation|
Copyright©2009 PR Newswire.
All rights reserved